Wait… How Real Are Humanoids Right Now?
Wait… How Real Are Humanoids Right Now?
YouTube1 hr 3 min
Watch on YouTube
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights
  • For a long-term, high-risk robotics investment, consider researching RoboStrategy (BOT) as the most direct public-market access discussed to private robotics companies; review its fees, holdings, valuations, and performance before investing.
  • Treat BOT as a 5–10+ year bet, and size any position for substantial uncertainty and the possibility that portfolio companies fail.
  • Favor evidence of reliable, repeatable commercial deployments and scalable manufacturing over demos; the discussion suggests industrial and commercial uses may arrive sooner than widespread home robotics.
  • Tesla (TSLA) offers broader public exposure that includes robotics, but the insights provide no specific robotics revenue, confirmed production figures, or valuation case to support a trade.
Detailed Analysis

RoboStrategy (BOT)

  • RoboStrategy describes itself as a publicly traded, closed-end venture fund focused on robotics, physical AI, and emerging technologies. Its stated purpose is to give public-market investors exposure to private robotics companies that may otherwise be difficult to access.
  • The fund says it has made investments in Figure AI, Maven Robotics, Dyna Robotics, Dexmate, and Standard Bots.
  • The speakers describe a long-term investment horizon—5 to 10 years or more—and say they expect many companies in the sector to fail as well as produce winners.

Takeaways

  • BOT is the most direct public-market exposure discussed to the fund’s private robotics portfolio, but it is not a single-company robotics investment.
  • The discussion does not provide details on BOT’s fees, portfolio weights, valuation, or financial performance. Review those factors, along with the fund’s holdings and risks, before considering an investment.
  • The speakers’ long time horizon and expectation of many losers point to substantial uncertainty; this is not a near-term, low-risk sector bet.

Figure AI (Private)

  • Andrew Kang said he invested $19 million in Figure early on and cited a $39 billion valuation for the company.
  • The speakers reported that Figure had scaled to more than 1,000 robots and was producing hundreds per month. They described robots being used for internal tasks such as cleaning, logistics, and walking through company facilities.
  • They said Figure is testing robots across a range of tasks and evaluating reliability, throughput, durability, and performance in real settings—not just whether a robot can complete a brief demonstration.
  • Figure has also created Index, a wholly owned subsidiary described as collecting human task videos to help train robots.
  • The speakers highlighted manufacturing scale and customer qualification as potential advantages: once a robot is integrated and trusted at a customer site, replacing it could be costly and risky.

Takeaways

  • The discussion’s strongest positive evidence for Figure is scale and repeated use, rather than a single impressive demo.
  • For investors evaluating Figure indirectly through a fund such as BOT, the key questions raised by the episode are whether Figure can improve reliability, manufacture at scale, and complete longer workflows with less human intervention.
  • The $39 billion valuation is a substantial valuation reference, not a price target or assurance of future returns.

Tesla (TSLA)

  • Tesla is described as a public company with substantial potential in robotics, but the speakers caution that it is not a humanoid-robotics pure play.
  • The speakers said Tesla had been relatively private about its robot-production numbers and referenced a plan to use 20,000 robots in a university for training. They also suggested Tesla may be collecting data, but did not confirm details.

Takeaways

  • Tesla offers public exposure to robotics alongside its other businesses, so its performance should not be treated as a direct measure of the humanoid-robotics sector.
  • The episode provides no specific Tesla robotics revenue, production target confirmation, or valuation analysis.

Xpeng (XPEV)

  • Xpeng was mentioned in the host’s opening question as an example of a Chinese company with a humanoid robot reportedly walking off an automated production line.
  • The guests did not discuss Xpeng’s robot, commercial plans, or investment prospects in detail.

Takeaways

  • The reference is a brief comparison point, not an investment thesis. The episode does not provide enough company-specific information to assess Xpeng’s robotics opportunity.

Maven Robotics (Private)

  • RoboStrategy said it recently led an investment in Maven Robotics.
  • The company was described as working on automated industrial robotics, including a “semi-humanoid” approach. The speakers noted that its use case can rely on traditional end-of-arm tooling rather than humanoid hands when that better supports speed and throughput.

Takeaways

  • The discussion emphasizes matching the robot’s design to the job: a specialized tool may be more practical than a human-like hand for a narrowly defined industrial task.
  • No valuation, deployment scale, or financial results were provided.

Dyna Robotics (Private)

  • RoboStrategy identified Dyna Robotics as a portfolio company and said it had previously demonstrated tasks such as folding towels, napkins, and clothes—work the guests linked to costs in hospitality and laundromats.
  • The speakers said Dyna had expanded to workflows involving tasks such as pharmacy dispensing and food preparation, and described robots handling a laundry process from collecting towels through washing, drying, and sorting.
  • Andrew Kang cited a million hours of human video data collected for research and said the company’s work helped test whether scaling data could improve robot performance.

Takeaways

  • The episode’s positive case for Dyna centers on moving from isolated demonstrations to longer, multi-step workflows.
  • Track whether these capabilities work reliably in customer settings and at useful throughput; the transcript does not provide commercial revenue or deployment figures.

Dexmate (Private)

  • Dexmate was named as one of RoboStrategy’s portfolio investments.
  • The guests did not provide details about its products, customers, deployment status, or performance.

Takeaways

  • The episode offers too little company-specific information to form an independent investment view.

Standard Bots (Private)

  • Standard Bots was named as a portfolio company.
  • Scott Walter briefly referred to a “standard bot” while showing a product on screen, but the discussion did not provide meaningful details about the company’s business or investment prospects.

Takeaways

  • No specific investment conclusion can be drawn from the limited remarks.

Unitree Robotics (“Unitary” in the transcript; access and status unclear)

  • The speakers described Unitree as a humanoid-robotics pure play and said access could be difficult for many U.S. investors.
  • The conversation also included an imprecise reference to the company having “just went public” and to a valuation figure. The discussion did not clarify the company’s listing status or substantiate the valuation, so those remarks should not be treated as verified facts.

Takeaways

  • Confirm the company’s current listing status, investor access, and valuation from reliable sources before drawing conclusions or attempting to invest.
  • The transcript does not provide a detailed view of Unitree’s products or commercial progress.

Agility Robotics (Private; potential public-market transaction discussed)

  • RoboStrategy said Agility might become an early North American humanoid pure play through a SPAC reverse merger later in the fall.
  • This was presented as an expected future transaction, not a completed listing.

Takeaways

  • Treat the potential transaction as a forward-looking statement from the discussion. Verify whether it occurs, and review the eventual terms and disclosures before considering any related investment.

Sunday (Private)

  • Sunday was mentioned as a company using a workforce and specialized UMI grippers to collect human task data for robot training.
  • The speakers also suggested Sunday could have applications in homes, while noting that early home robots may be limited in capability and could rely on wheeled designs or human assistance.

Takeaways

  • Data collection is presented as an important part of building robot intelligence, but the episode does not provide company-specific commercial or financial information.

1X Neo (Private)

  • 1X Neo was cited as an example of a home robot that may initially operate with teleoperation—human remote assistance—rather than full autonomy.
  • The speakers said early home robots may need occasional remote intervention and raised privacy concerns around cameras and in-home data.

Takeaways

  • The discussion suggests that early home-robot products may not be fully autonomous. Investors should distinguish limited, assisted deployments from claims of general-purpose home capability.

Robotics and Physical AI (Investment Theme)

  • The guests were broadly bullish on physical AI and robotics, arguing that robots are improving and that some deployments are happening privately, beyond what is visible in public demonstrations.
  • They emphasized that investment progress should be assessed by reliability, quality, throughput, and ability to complete real workflows, rather than research papers or demo videos alone.
  • The speakers described industrial and commercial uses—such as factories, logistics, laundry, hospitality, pharmacies, and food preparation—as nearer-term opportunities than widespread home use.
  • They estimated that some businesses might be willing to pay around $100,000 or more per year to lease a humanoid robot, based on the value of operating it across multiple shifts. This was the guests’ estimate, not a firm market price.
  • They said home adoption could take longer, with broad household use potentially arriving in the 2030s. They cited industrial demand, limited supply, home safety, general-purpose capability, and privacy as factors that could delay it.
  • They described substantial technical and commercial challenges:
    • Robot hands and other hardware can wear out, break, or lose accuracy.
    • Bodies need to handle payloads and run without overheating.
    • Data and compute must be applied to effective model designs; otherwise, companies could waste large sums.
    • Companies need to design for manufacturing, qualify suppliers, and conduct durability testing.
    • Safety standards for robots, particularly in homes, remain unresolved.
    • Home robots raise privacy concerns because they may use cameras and collect data inside people’s homes.
  • The speakers acknowledged that many startups will fail and that selecting winners is difficult. They cited founder quality, technical diligence, manufacturing plans, and defensible advantages as factors RoboStrategy considers.

Takeaways

  • A practical way to assess the sector, based on the discussion, is to prioritize evidence of repeatable deployments, useful throughput, reliability, and progress toward scalable manufacturing over promotional demonstrations.
  • Commercial and industrial applications appear closer to adoption than general-purpose home robots, but the timing and financial returns remain uncertain.
  • The episode provides a bullish industry thesis, not a reliable forecast of company-level returns. It gives no specific stock price targets or direct buy recommendations.

Ask about this postAnswers are grounded in this post's content.
Video Description
Humanoid robots are improving fast, but flashy demos still hide the harder question: how many are actually working reliably in the real world? Today we separate the hype from deployment. 00:00 State of Robotics Today 01:42 Demos vs Deployments 09:02 Public Investing Access 16:55 Hardware and AI Bottlenecks 22:38 Physical Intelligence ROI 29:27 Figure Field Notes 34:11 AI Breakthroughs and Scaling 37:51 Robot Demand Outpaces Supply 41:10 Robotics iPhone Moment 47:12 Human Video Scaling Unlock 53:55 Humanoids in Homes Timeline 01:00:14 Safety Privacy and Standards Follow RoboStrategy on: X/Twitter: https://x.com/RoboStrategy LinkedIn: https://www.linkedin.com/company/robostrategy/ Scott Walter: https://x.com/GoingBallistic5 Herbert Ong: https://x.com/HerbertOng Disclaimer: RoboStrategy, Inc. (Nasdaq: BOT) is a closed-end investment company registered under the Investment Company Act of 1940. Risks include the possible loss of up to 100% of invested capital, and there is no assurance the Fund's investment objective will be achieved. Shares are not bank guaranteed and are not insured by the FDIC. FP Strategies LLC (RoboStrategy Advisors) is the Fund's investment adviser. Views are those of the speaker and not necessarily those of the Fund or its Board. This discussion is provided for information and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Forward-looking statements and opinions are based on current expectations, estimates, projections, and assumptions and are subject to change without notice. Actual outcomes and results may differ materially from those expressed or implied. Past performance is no guarantee of future results. Any references to prior investment experience, portfolio companies, or investment outcomes related to activities conducted outside of RoboStrategy are provided solely for background and informational purposes. Any referenced gains, returns, or investment outcomes may be unrealized, do not represent the performance of any RoboStrategy fund, and are not indicative of future results or future investment outcomes for RoboStrategy. Investing involves risk, including possible loss of principal. Shares of closed-end funds may trade at a premium or a discount to net asset value, and market price and net asset value will differ. Neither the Fund nor the Adviser can predict whether shares will trade at, below, or above net asset value. References to companies, technologies, or investments are illustrative only and should not be interpreted as investment recommendations. Investors should consider the Fund's investment objectives, risks, charges, and expenses carefully before investing. This and other information is in the Fund's prospectus and reports, available at www.robostrategy.co/investor-center and at sec.gov. All views expressed are personal opinion as of date of recording and are subject to change without responsibility to update views.  No guarantee is given regarding the accuracy of information on this channel.  Neither host or guests can be held responsible for any direct or incidental loss incurred by applying any of the information offered. Author is an investor in RoboStrategy, Inc. (Nasdaq: BOT).
About RoboStrategy
RoboStrategy

RoboStrategy

By @robostrategy

RoboStrategy (NASDAQ: BOT) is the first fund dedicated to investing in the leading private robotics companies through a publicly listed investment company. Built to compound exposure. Leading robotics companies are still private, $BOT gives you access to them. Portfolio includes Figure AI, Apptronik, Standard Bots, Path Robotics, Dexmate, DYNA Robotics, and more.